TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 57 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,000 | 0.0% | 800 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 800 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | -50.0% | 800 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $2,000 | -33.3% | 800 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $3,000 | 0.0% | 800 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $3,000 | -40.0% | 800 | 0.0% | 0.00% | -50.0% |
| Q3 2016 | $5,000 | +25.0% | 800 | 0.0% | 0.00% | +100.0% |
| Q2 2016 | $4,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |